Literature DB >> 19121800

Left bundle branch-Purkinje system in patients with bundle branch reentrant tachycardia: lessons from catheter ablation and electroanatomic mapping.

Boris Schmidt1, Min Tang, K R Julian Chun, Matthias Antz, Roland R Tilz, Andreas Metzner, Bulent Koektuerk, Ping Xie, Karl-Heinz Kuck, Feifan Ouyang.   

Abstract

BACKGROUND: The mechanism of bundle branch reentrant tachycardia has been described, and ablation of the right bundle branch (RBB) is a curative approach.
OBJECTIVE: The purpose of this study was to evaluate the left bundle branch (LBB)-Purkinje system during sinus rhythm and to test the feasibility of ablating the LBB in patients with bundle branch reentrant tachycardia.
METHODS: Thirteen consecutive male patients (age 62 +/- 12 years) with sustained bundle branch reentrant tachycardia were included in the study.
RESULTS: Surface ECG before ablation showed left bundle branch block (LBBB) in 10 patients and a narrow QRS in 3 patients. Bundle branch reentrant tachycardia with LBBB morphology was inducible in all cases. Ablation of the RBB resulted in right bundle branch block (RBBB) on surface ECG in 8 of 9 patients and total AV block with preserved retrograde conduction over the LBB in 1 of 9 patients. In 4 patients with LBBB during sinus rhythm, electroanatomic mapping showed (1) absent conduction through the anterior fascicle of the LBB and (2) anterograde slow conduction through the posterior fascicle of the LBB with (3) left ventricular activation by transseptal conduction due to conduction block between the distal Purkinje and the local ventricle in 2 of 4 patients. The LBB was successfully ablated in these 4 patients. During mean follow-up of 48 +/- 29 months, 3 patients died, but bundle branch reentrant tachycardia did not recur in any patient.
CONCLUSION: In patients with LBBB and bundle branch reentrant tachycardia, anterograde slow conduction over the LBB is present. Ablation of the LBB is feasible and may be an alternative approach for bundle branch reentrant tachycardia. Patients with normal heart and bundle branch reentrant tachycardia have a good prognosis and may not require further intervention.

Entities:  

Mesh:

Year:  2008        PMID: 19121800     DOI: 10.1016/j.hrthm.2008.09.028

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  11 in total

1.  2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.

Authors:  Edmond M Cronin; Frank M Bogun; Philippe Maury; Petr Peichl; Minglong Chen; Narayanan Namboodiri; Luis Aguinaga; Luiz Roberto Leite; Sana M Al-Khatib; Elad Anter; Antonio Berruezo; David J Callans; Mina K Chung; Phillip Cuculich; Andre d'Avila; Barbara J Deal; Paolo Della Bella; Thomas Deneke; Timm-Michael Dickfeld; Claudio Hadid; Haris M Haqqani; G Neal Kay; Rakesh Latchamsetty; Francis Marchlinski; John M Miller; Akihiko Nogami; Akash R Patel; Rajeev Kumar Pathak; Luis C Saenz Morales; Pasquale Santangeli; John L Sapp; Andrea Sarkozy; Kyoko Soejima; William G Stevenson; Usha B Tedrow; Wendy S Tzou; Niraj Varma; Katja Zeppenfeld
Journal:  J Interv Card Electrophysiol       Date:  2020-10       Impact factor: 1.900

Review 2.  Prevention of sudden cardiac death beyond the ICD: have we reached the boundary or are we just burning the surface?

Authors:  Niyada Naksuk; Christopher V DeSimone; Suraj Kapa; Samuel J Asirvatham
Journal:  Indian Heart J       Date:  2014-01-03

Review 3.  [Bundle branch reentry VT : Diagnosis, mapping, and ablation].

Authors:  Christopher Reithmann
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2017-05-08

Review 4.  Ventricular arrhythmias and the His-Purkinje system.

Authors:  Michel Haissaguerre; Edward Vigmond; Bruno Stuyvers; Meleze Hocini; Olivier Bernus
Journal:  Nat Rev Cardiol       Date:  2016-01-04       Impact factor: 32.419

5.  2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.

Authors:  Edmond M Cronin; Frank M Bogun; Philippe Maury; Petr Peichl; Minglong Chen; Narayanan Namboodiri; Luis Aguinaga; Luiz Roberto Leite; Sana M Al-Khatib; Elad Anter; Antonio Berruezo; David J Callans; Mina K Chung; Phillip Cuculich; Andre d'Avila; Barbara J Deal; Paolo Della Bella; Thomas Deneke; Timm-Michael Dickfeld; Claudio Hadid; Haris M Haqqani; G Neal Kay; Rakesh Latchamsetty; Francis Marchlinski; John M Miller; Akihiko Nogami; Akash R Patel; Rajeev Kumar Pathak; Luis C Sáenz Morales; Pasquale Santangeli; John L Sapp; Andrea Sarkozy; Kyoko Soejima; William G Stevenson; Usha B Tedrow; Wendy S Tzou; Niraj Varma; Katja Zeppenfeld
Journal:  Europace       Date:  2019-08-01       Impact factor: 5.214

6.  The risk of delayed atrioventricular and intraventricular conduction block following ablation of bundle branch reentry.

Authors:  Christopher Reithmann; Bernhard Herkommer; Adrien Huemmer; Franz von Hoch; Michael Fiek
Journal:  Clin Res Cardiol       Date:  2012-09-27       Impact factor: 5.460

Review 7.  [Ventricular tachycardias originating in the his-purkinje system. Bundle branch reentrant ventricular tachycardias and fascicular ventricular tachycardias].

Authors:  Boris Schmidt; Kyoung Ryul Julian Chun; Karl-Heinz Kuck; Feifan Ouyang
Journal:  Herz       Date:  2009-11       Impact factor: 1.443

Review 8.  Ventricular arrhythmias involving the His-Purkinje system in the structurally abnormal heart.

Authors:  Beixin Julie He; Penelope Boyden; Melvin Scheinman
Journal:  Pacing Clin Electrophysiol       Date:  2018-08-27       Impact factor: 1.976

9.  Bundle branch reentrant ventricular tachycardia after transcatheter aortic valve replacement.

Authors:  Gurjit Singh; Marc K Lahiri; Arfaat Khan; Claudio D Schuger
Journal:  HeartRhythm Case Rep       Date:  2017-01-09

10.  Incessant bundle branch reentrant ventricular tachycardia in a patient with corrected transposition of the great arteries.

Authors:  Ken Kato; Daigo Yagishita; Koichiro Ejima; Tetsuyuki Manaka; Morio Shoda; Nobuhisa Hagiwara
Journal:  HeartRhythm Case Rep       Date:  2015-06-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.